VIRBAC AH, INC. — TTAB Proceedings
VIRBAC AH, INC. is a party to 2 TTAB proceedings.
Proceedings
- Proceeding 91284009 — Oppositions, Terminated (filed 2023-03-19) against Genzyme Corporation as defendant
- Proceeding 97131271 — Extensions of Time to Oppose, Terminated (filed 2022-10-19) against Genzyme Corporation as defendant
Marks in These TTAB Matters
Recent Live Filings
- SOLOXINE — Pending, filed 2024-12-04
- MOVODYL — Registered, filed 2021-11-18
- SENSISNACKS — Registered, filed 2021-11-03
- KERATOLUX — Registered, filed 2004-04-30
- CLINTABS — Registered, filed 2003-12-18
- GENESIS — Registered, filed 2002-05-06
- KETOCHLOR — Registered, filed 2000-06-14
- ALLERDERM OMEGADERM — Registered, filed 1998-08-12
- OTOMITE PLUS — Registered, filed 1996-07-18
- ALLERDERM EFA-CAPS — Registered, filed 1996-01-05
- HEXADENE — Registered, filed 1995-12-20
- CORTISOOTHE — Registered, filed 1993-12-21
- EPI-SOOTHE — Registered, filed 1991-07-29
- EUTHASOL — Registered, filed 1991-02-14
- BIOMOX — Registered, filed 1989-11-16
Common TTAB Counterparties
- Genzyme Corporation — 2 proceedings
Recent TTAB Timeline
- 2023-08-01: 91284009 — TERMINATED involving Genzyme Corporation
- 2023-08-01: 91284009 — BD'S DECISION: DISMISSED W/ PREJUDICE involving Genzyme Corporation
- 2023-06-28: 91284009 — MOT TO AMEND APPLICATION involving Genzyme Corporation
- 2023-06-27: 91284009 — SUSPENDED involving Genzyme Corporation
- 2023-06-27: 91284009 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Genzyme Corporation
- 2023-05-26: 91284009 — SUSPENDED involving Genzyme Corporation
- 2023-05-26: 91284009 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Genzyme Corporation
- 2023-04-27: 91284009 — SUSPENDED involving Genzyme Corporation
- 2023-04-27: 91284009 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Genzyme Corporation
- 2023-03-19: 91284009 — PENDING, INSTITUTED involving Genzyme Corporation
- 2023-03-19: 91284009 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Genzyme Corporation
- 2023-03-19: 91284009 — FILED AND FEE involving Genzyme Corporation
- 2023-01-18: 97131271 — EXTENSION OF TIME GRANTED involving Genzyme Corporation
- 2023-01-18: 97131271 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Genzyme Corporation
- 2022-10-19: 97131271 — EXTENSION OF TIME GRANTED involving Genzyme Corporation
- 2022-10-19: 97131271 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Genzyme Corporation